Japan Animal Referral Medical Center Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
720.00
491.00
533.00
423.00
411.00
451.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
232.00
168.00
-46.00
-5.00
12.00
-42.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,372.00
899.00
810.00
557.00
504.00
537.00
Cash Flow from Investing Activities
-994.00
-985.00
-784.00
-1,425.00
-69.00
-93.00
Cash Flow from Financing Activities
-608.00
-392.00
820.00
722.00
-469.00
-445.00
Net Cash Inflow / Outflow
-230.00
-478.00
847.00
-146.00
-34.00
-1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Japan Animal Referral Medical Center Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
720.263
499
221.00
44.34%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
232.316
1304
-1,072.00
-82.18%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1372.376
2444
-1,072.00
-43.85%
Cash Flow from Investing Activities
-994.383
-321
-673.00
-209.78%
Cash Flow from Financing Activities
-608.029
-144
-464.00
-322.24%
Net Cash Inflow / Outflow
-230.035
1979
-2,209.00
-111.62%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 52.52% vs 10.96% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,372.38
899.78
52.52%






